Aktas_2017_Arch.Pharm.(Weinheim)_350_

Reference

Title : Novel NHC Precursors: Synthesis, Characterization, and Carbonic Anhydrase and Acetylcholinesterase Inhibitory Properties - Aktas_2017_Arch.Pharm.(Weinheim)_350_
Author(s) : Aktas A , Taslimi P , Gulcin I , Gok Y
Ref : Arch Pharm (Weinheim) , 350 : , 2017
Abstract :

Three series of imidazolidinium ligands (NHC precursors) substituted with 4-vinylbenzyl, 2-methyl-1,4-benzodioxane, and N-propylphthalimide were synthesized. N-Heterocyclic carbene (NHC) precursors were prepared from N-alkylimidazoline and alkyl halides. The novel NHC precursors were characterized by (1) H NMR, (13) C NMR, FTIR spectroscopy, and elemental analysis techniques. The enzymes inhibition activities of the NHC precursors were investigated against the cytosolic human carbonic anhydrase I and II isoenzymes (hCA I and II) and the acetylcholinesterase (AChE) enzyme. The inhibition parameters (IC50 and Ki values) were calculated by spectrophotometric method. The inhibition constants (Ki ) were found to be in the range of 166.65-635.38 nM for hCA I, 78.79-246.17 nM for hCA II, and 23.42-62.04 nM for AChE. Also, the inhibitory effects of the novel synthesized NHCs were compared to acetazolamide as a clinical CA isoenzymes inhibitor and tacrine as a clinical cholinergic enzymes inhibitor.

PubMedSearch : Aktas_2017_Arch.Pharm.(Weinheim)_350_
PubMedID: 28464340

Related information

Citations formats

Aktas A, Taslimi P, Gulcin I, Gok Y (2017)
Novel NHC Precursors: Synthesis, Characterization, and Carbonic Anhydrase and Acetylcholinesterase Inhibitory Properties
Arch Pharm (Weinheim) 350 :

Aktas A, Taslimi P, Gulcin I, Gok Y (2017)
Arch Pharm (Weinheim) 350 :